• John Quackenbush, Ph.D., Professor of Biostatistics and Computational Biology, Dana-Farber Cancer Institute
• Michael Liebman, Ph.D., Managing Director, Strategic Medicine, Inc. & Senior Institute Fellow at the Windber Research Institute
• Jonathan Sheldon, CSO, InforSense

There is no cost to attend the Translational Research Symposium. However, due to limited space InforSense reserves the right to limit attendance at this event. To request an invitation please email information@inforsense.com.

This course is for everyone who wants to get started and quickly become productive using the powerful features of InforSense. Course participants will be taught in an interactive environment how to get the most out of their data, using the flexibility of InforSense workflows, and to create information-rich web-applications with VisualSense.

A small number of places are still available for this event; we recommend that you book early.

Date: 15 - 16 October 2008

Location:
InforSense Training Centre
100 Hammersmith Road, London, W6 7JP
Directions

Price:
The special rate for this 2-Day Training Course, including all course materials, lunches and refreshments is £750 + VAT.

Contact:
For all other inquiries including assistance with travel and accommodation please contact training@inforsense.com

For more details about the training course and to register please click here. 

As part of the agreement, InforSense will represent Pharsight’s market-leading software for pharmacokinetic and pharmacodynamic (PK/PD) analysis, reporting, archiving, and data visualization. InforSense will provide distribution services for Pharsight within the Chinese pharmaceutical and biotech research and development market, including sales and marketing, end-user training, and maintenance and support services.

Pharsight and InforSense have also initiated a strategic partnership to deliver translational research solutions to the pharmaceutical industry. The strategic partnership includes opportunities for product-based collaborations to utilize biomarkers in clinical PK/PD modeling.

“This agreement strengthens Pharsight’s ability to take advantage of the exceptional growth opportunities in China as research and development activities expand,” said Daniel L. Weiner, Ph.D., senior vice president and chief technology officer at Pharsight. “There is a strong demand in our customer base for more dynamic analysis and visualization of PK/PD data and the integration of genotypic and other biomarker data. Partnering with InforSense will enable Pharsight to take advantage of their flexible, high-throughput analytics technology and expertise with molecular data to enable more effective PK/PD modeling. We look forward to a successful distribution alliance and fruitful collaboration, based on the respective strengths of each company’s tools and technologies.”

“Pharsight’s tools are a fundamental requirement in PK/PD, particularly in the pharmaceutical industry, and we are pleased to be working with them in this area,” said Jonathan Sheldon, Ph.D., chief scientific officer at InforSense. “Bringing together our capabilities in genotypic and other molecular analysis with Pharsight’s PK/PD tools and expertise is a major step towards making the goal of translational research a reality.”

To initiate the partnership, Pharsight will participate at several events sponsored by InforSense in Shanghai, China on November 3-5, 2008, as part of the First International Meeting on Drug Discovery Pipeline and Informatics Solutions. On November 3, Daniel L. Weiner, Ph.D., Pharsight senior vice president and chief technology officer, will speak to conference attendees on the strategic value of modeling and simulation for improving the efficiency of clinical drug development. On November 4-5, Dr. Weiner will lead an applied training workshop on PK/PD data analysis and modeling methods, utilizing Pharsight’s WinNonlin® software.

More information about this event is available at www.drugdiscovery-china.cn.

About InforSense, Ltd.

InforSense goes beyond traditional business intelligence to provide a completely integrated suite of agile, visual and predictive intelligence solutions, enabling organizations to gain business and scientific insights and optimize their business-critical decision-making processes. Leading pharmaceutical, biotechnology, consumer goods, healthcare, financial services, manufacturing and communications companies around the world rely on InforSense to quickly, easily deliver intelligence and identify trends in data. 

The company is privately held, with European headquarters in London, UK and North American headquarters in Cambridge, Massachusetts. For more information visit www.inforsense.com.

About Pharsight Corporation 

Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. The company's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.

Pharsight’s approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and

phase of their business and scientific processes. Pharsight Corporation is headquartered in Mountain View, California. More information is available at www.pharsight.com.

Forward Looking Statements

The statements in this press release related to the performance of Pharsight software products in China and Pharsight’s strategic partnership with InforSense Ltd. are forward-looking statements. Forward-looking statements are inherently speculative, and actual results may differ materially from Pharsight's expectations due to a variety of factors, including: changes in FDA regulations may affect demand for the product and services; and customers may not perceive the benefits of the products and services to be the same as Pharsight believes them to be. Other risk factors relating to Pharsight are disclosed in the company's most recent Form 10-K filed with the Securities and Exchange Commission on August 13, 2008. All forward-looking statements are based on information available to the company on the date hereof, and the company assumes no obligation to update such statements.

Registered Trademarks and Trademarks

Pharsight and WinNonlin are registered trademarks of Pharsight Corporation.  InforSense and the InforSense logo are registered trademarks of InforSense Limited. All other brand or product names mentioned in this document are trademarks or registered trademarks of their respective companies or organizations.

London, UK and Cambridge, MA, October 6, 2008 – InforSense Ltd., the leading provider of next-generation business and scientific intelligence tools, today announced that it has named InforA, a leading analytics consulting firm based in Turkey, as InforSense European, Middle East, and Africa (EMEA) Partner of the Year.  This award recognizes InforA for outstanding achievement in new business development.

As a professional consulting company, InforA provides advanced data analytics capabilities to financial services, telecommunications and manufacturing industries as well as the public sector in Europe and Turkey.  InforA has been a notable member of InforSense’s PartnerSense program since 2005, experiencing a 100% increase in sales growth over the past year and securing several strategic new customers including ING Bank, Koc Finance, and Tekstil Bank.

"We are honored to be recognized by InforSense with this prestigious award," said Ali Alkan, Chief Executive Officer and Founder of InforA.  "The InforSense platform enables organization to rapidly and easily create dynamic analytic mash-ups from large amounts of complex, disparate data, of any type from any location.  With InforSense we have been able to deliver strategic analytical solutions that address our joint customer’s requirements for credit risk management.”

“We are pleased to bestow InforA with our EMEA Partner of the Year Award,” said David Bennett, Executive Vice President, Worldwide Sales at InforSense.  “Their significant expertise in the finance industry has been instrumental in securing new projects at the region’s leading financial institutions.”

About InforA

InforA is a professional data analytics consulting company that serves the financial services, telecommunications and manufacturing industries as well as the public sector in the European and Turkish markets. Its highly-educated team uses data mining techniques to transform gathered data into meaningful information that improves organization’s decision making process in terms of time and accuracy. Using InforSense and Oracle technologies InforA provides data analysis solutions to the leading banks, credit institutions and consulting companies of Turkey for credit scoring, risk management and customer understanding.

About InforSense

InforSense goes beyond traditional business intelligence to provide a completely integrated suite of agile, visual and predictive intelligence solutions, enabling organizations to gain business and scientific insights and optimize their business-critical decision-making processes. Leading pharmaceutical, biotechnology, consumer goods, healthcare, financial services, manufacturing and communications companies around the world rely on InforSense to quickly, easily deliver intelligence and identify trends in data.  The company is privately held, with European headquarters in London, UK and North American headquarters in Cambridge, Massachusetts.

Dr. Moustafa Ghanem, Director of Research, InforSense will present at the conference on "Using the InforSense Platform to Share Workflows across Virtual Organizations."

“Our customers typically use a variety of best-of-breed tools to meet their specific scientific or business analytic needs. The new PartnerSense Program allows us to work closely with industry leaders to develop and implement integrative, cross-platform solutions for our mutual customers,” said David Bennett, Executive Vice President of Worldwide Sales at InforSense.  “By combining our award winning InforSense business intelligence platform and our partners’ specific domain expertise and solutions, we are able to advance our vision of embedding analytic intelligence across the enterprise.”

The InforSense PartnerSense Program will support many types of organizations, regardless of size and market reach.   The new program offers support from the discovery stage through joint planning and market and product development, as well as support for production applications and enterprise customers.  Types of partnerships available include Value Added Reseller, Technology & OEM Partner, System Integrator/Services Provider, Marketing Partner and Distributor Partner.

The PartnerSense Program comprises three modules:

• The Business Module, which ensures that InforSense and its partners are fully aligned in their joint go-to market endeavors
• The Enable Module, which offers a range of discounted options for partners to gain momentum through easy access to InforSense development skills and support.
• The Communicate Module, which offers co-marketing opportunities designed to ensure maximum return on joint investments by a partner and InforSense

The PartnerSense Program will also strengthen its current partnerships by formalizing program processes to decrease development time and the securing of new business. InforSense currently works with leaders from various market segments across the globe including Apple, The BioTeam, BioWisdom, Chemical Computing Group (CCG), ChemAxon, ChemNavigator, Data Miners, Daylight, DeltaSoft Inc., Elsevier MDL, GeneGo, GenomeQuest, Inc., InforA, Ingenuity Systems, Linguamatics, Prometheus Asia, Oracle, Spotfire, and Tripos.

For more information about the InforSense PartnerSense Program, go to http://www.inforsense.com/partners/inforsense_partnersense_program/

About InforSense

InforSense goes beyond traditional business intelligence to provide a completely integrated suite of agile, visual and predictive intelligence solutions, enabling organizations to gain business and scientific insights and optimize their business-critical decision-making processes. Leading pharmaceutical, biotechnology, consumer goods, healthcare, financial services, manufacturing and communications companies around the world rely on InforSense to quickly, easily deliver intelligence and identify trends in data.  The company is privately held, with European headquarters in London, UK and North American headquarters in Cambridge, Massachusetts.

For more information visit www.inforsense.com

Proteome Discoverer’s protein annotation capabilities are based on workflows jointly developed by Thermo Fisher Scientific and InforSense. The workflows perform automated annotation of proteomics data using information from NCBI and SWISS-PROT to provide biological context to experimental data. The workflows in Proteome Discoverer are powered by the IVM: a lightweight, analytical workflow execution engine that can run on a wide variety of platforms including workstations, servers, scientific instrumentation, and mobile devices. As a result of its small footprint, it is effortlessly installed and simple to maintain, update and extend, eliminating the complexity typically found with traditional software installations.

Proteome Discoverer is fully compatible with the InforSense 5.0 platform, and customers will be able to build their own annotation workflows and share them via the InforSense CustomerHub on-line community. Users of Proteome Discoverer can upgrade to a full InforSense license to build their own analytical workflows and integrate internal data to provide further annotation.

“As proteomics has evolved, the need to support advanced and flexible annotation of proteomics data has grown. The IVM gives us the power and flexibility to support the changing requirements of our customers,” said Andreas Hühmer, Proteomics Marketing Director, Thermo Fisher Scientific. “The ability to update client software without performing a new distribution and installation is a major advantage to us, reducing our costs and improving our ability to respond to our customers.”

“Today’s announcement is an important milestone for Thermo Fisher and InforSense, and we are delighted to have worked closely with them to introduce the first Virtual Machine-based product to the market,” said Prof. Yike Guo, Founder and Chief Executive Officer of InforSense Ltd. “Our work with Thermo Fisher Scientific is a key collaboration for us and illustrates how our next generation scientific business intelligence technology is effectively automating data integration and analysis tasks. We believe that this real time analytics model is an important step forward for the life sciences industry.”

About Proteome Discoverer

Proteome Discoverer is a new proteomics analysis software platform that gives scientists the most comprehensive view of quantitative and qualitative proteomic data available today. It enables researchers to combine and compare data from multiple search engines, public databases, and dissociation methods on a larger scale than ever possible, in a program that is easy-to-use and flexible.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling customers to make the world healthier, cleaner and safer. With annual revenues of $10 billion, the company has more than 30,000 employees and serves over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, the company helps solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, the company offers the most convenient purchasing options to customers and continuously advances its technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit www.thermofisher.com.

About InforSense

InforSense goes beyond traditional business intelligence to provide a completely integrated suite of agile, visual and predictive intelligence solutions, enabling organizations to gain business and scientific insights and optimize their business-critical decision-making processes. Leading pharmaceutical, biotechnology, consumer goods, healthcare, financial services, manufacturing and communications companies around the world rely on InforSense to quickly, easily deliver intelligence and identify trends in data.  The company is privately held, with European headquarters in London, UK and North American headquarters in Cambridge, Massachusetts.

For more information visit www.inforsense.com.

Dana Farber Case Study: Leveraging Business Intelligence technologies to support Translational Medicine

Mick Correll, Director of Healthcare Product Management, InforSense will present a case study on Dana Farber Cancer Institute where InforSense and Oracle technology is used to integrate clinical, sample and research data to better understand diseases and improve patient care.

Dana Farber Case Study: Leveraging Business Intelligence technologies to support Translational Medicine

Mick Correll, Director of Healthcare Product Management, InforSense will present a case study on Dana Farber Cancer Institute where InforSense and Oracle technology is used to integrate clinical, sample and research data to better understand diseases and improve patient care.

Visit InforSense in Booth #405 and learn how InforSense goes beyond traditional business intelligence to provide a completely integrated suite of agile, predictive and visual BI solutions.

Visitors to the booth can also enter for a chance to win a Garmin nuvi 260 GPS Navigation.

To set up a meeting at TDWI San Diego, send an email to information@inforsense.com.